Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group. - Wikidata - wikimedia - TriplyDB

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

http://www.wikidata.org/entity/Q33614496

about

Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist?Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group Sudden deaths in psychiatric patients A man awaiting a double transplant.The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases.Beta-blocker use in systolic heart failure and dilated cardiomyopathy.Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival.Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.

P2860

Q35088168-953EE8BC-500D-4AD0-A60A-C565348E0EC5 Q35367363-7354BC85-DB31-498F-86DF-6F5019C1E487 Q35834580-A58DD814-8504-4D16-BEDD-7EBBAAAE0874 Q36070036-940F234D-92CC-48DC-A063-7E81A06F4680 Q38197734-08ED89A2-9791-46F7-8EE0-22ADFC12C3AF Q38464751-2A3DB775-3485-4A88-BE1D-74818CD3A983 Q50770493-70BD1420-DD60-4611-B752-BF7A40296C23 Q54328586-1B9DA363-F148-4571-9F27-0BCCFC77759D

P2860

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

http://www.wikidata.org/entity/Q33614496

description

1994 nî lūn-bûn

@nan

1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

@ast

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

@en

type

label

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

@ast

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

@en

prefLabel

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

@ast

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

@en

P1433

Q33614496-1B9D5023-8B67-4033-B535-91F2919B011D

P1476

Q33614496-AF96DC90-7836-4CDE-AE44-5A2F1A1D58C5

P2093

Q33614496-61EB564F-F91E-45D6-8AB0-B04A8DC87944

Q33614496-6A3ECE5E-AF27-408C-A2A8-527494ECBDA9

Q33614496-A17ED418-0FE3-44CA-8C1A-4DEF3B3A12AC

Q33614496-A71E891A-7C52-4B5B-B372-BCA96D923424

Q33614496-AB3FE1E7-E398-44B4-950A-34850941C1A5

Q33614496-C22DC190-210A-4B48-B92B-3FC4C8F01FE8

Q33614496-FD42DB6F-5DF7-4FCA-9173-5E3DB405D958

P2860

Q33614496-08DD58D0-DFC8-4395-B3ED-8F957E661C79

Q33614496-18FF38EF-3594-4780-8923-E999629AAA69

Q33614496-364474FF-94AF-457B-98B6-03710F8567EF

Q33614496-39ABAF57-7548-4D68-BC04-711AA4E769CF

Q33614496-6E696AC8-E761-41F1-9B54-E13ED9AFE790

Q33614496-7F45A41F-FC47-4D30-90C8-0EEB5344E821

Q33614496-80438E3D-D706-4B6A-AF70-98DBD6AD1BD2

Q33614496-9F1FE575-5187-421E-AD49-2CA4D7D8E735

Q33614496-A898985D-27E8-4E0A-89D4-90EAB36580BE

Q33614496-B0FFF2E2-9A70-4C7C-8C7F-DA38D8934BD9

P304

Q33614496-EA839654-2993-40F7-A96C-9AB82ABF7EE8

P31

Q33614496-2FB61698-49C0-47A0-A974-EA5F7DBD313F

P356

Q33614496-7ED0813C-B024-461E-ADC4-03EE8EE782DB

P433

Q33614496-AC7F72BE-04A9-4C02-B36E-C2035A91583E

P478

Q33614496-7084F350-8E1A-4556-8097-D615AD274874

P50

Q33614496-B933FFBB-F2E8-47F4-B66F-2FA7B31C7D1C

Q33614496-EB50356A-4F1E-45E6-8B7F-146D956E2512

P577

Q33614496-7D304150-169F-465C-8614-8BC299929B8A

P698

Q33614496-DA110AF6-6872-4CBF-ABCB-BF133F7F0C5F

P932

Q33614496-E064B117-E29B-4C45-9024-5E1CFB263E54

P356

HRT.72.6_SUPPL.S46

P1433

British heart journal

P1476

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group

@en

P2093

A Di Lenarda

http://www.w3.org/2001/XMLSchema#string

A Perkan

http://www.w3.org/2001/XMLSchema#string

B Pinamonti

http://www.w3.org/2001/XMLSchema#string

D Gregori

http://www.w3.org/2001/XMLSchema#string

F Camerini

http://www.w3.org/2001/XMLSchema#string

G Lardieri

http://www.w3.org/2001/XMLSchema#string

G Secoli

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Factors predicting mortality in idiopathic dilated cardiomyopathy.

The course of idiopathic dilated cardiomyopathy in New Zealand.

Prediction of outcome in dilated cardiomyopathy

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.

The natural history of idiopathic dilated cardiomyopathy.

The clinical course of idiopathic dilated cardiomyopathy. A population-based study.

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.

[Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients]

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy.

P304

S46-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.72.6_SUPPL.S46

http://www.w3.org/2001/XMLSchema#string

P433

6 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Zecchin

Gianfranco Sinagra

P577

1994-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7873326

http://www.w3.org/2001/XMLSchema#string

P932

1025677

http://www.w3.org/2001/XMLSchema#string